Advaxis Inc (ADXS)

8.92
NASDAQ : Health Care
Prev Close 8.83
Day Low/High 8.76 / 9.27
52 Wk Low/High 5.21 / 16.30
Avg Volume 759.40K
Exchange NASDAQ
Shares Outstanding 39.84M
Market Cap 351.82M
EPS -1.70
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Interesting ADXS Put And Call Options For December 16th

Interesting ADXS Put And Call Options For December 16th

Investors in Advaxis, Inc. saw new options become available this week, for the December 16th expiration.

INVESTOR ALERT: Levi & Korsinsky, LLP Announces An Investigation Involving Possible Breaches Of Fiduciary Duty By The Board Of Advaxis, Inc.

INVESTOR ALERT: Levi & Korsinsky, LLP Announces An Investigation Involving Possible Breaches Of Fiduciary Duty By The Board Of Advaxis, Inc.

Levi & Korsinsky announces it has commenced an investigation of Advaxis, Inc.

Think Big on These Small Biotechs

Think Big on These Small Biotechs

New drugs give small-cap companies opportunity to expand markets and revenues.

Don't Roll the Dice on Central Bank News

Don't Roll the Dice on Central Bank News

The bears are trying it out on the Bank of England news today, but they may get squeezed.

Amgen, Regeneron Forge New, Separate Cancer Immunotherapy Pacts

Amgen, Regeneron Forge New, Separate Cancer Immunotherapy Pacts

The new deals signal a long-term commitment from two of the largest biotech companies to focus on cancer immunotherapy as a platform for future growth.

Amgen And Advaxis Enter Global Cancer Immunotherapies Collaboration

Amgen And Advaxis Enter Global Cancer Immunotherapies Collaboration

Collaboration Will Advance Highly Targeted, Patient-Specific Treatment Approach